Lataa...
Mechanisms contributing to ado-trastuzumab emtansine-induced toxicities: a gateway to better understanding of ADC-associated toxicities
In order to improve the safety of novel therapeutic drugs, better understanding of the mechanisms of action is important. Ado-trastuzumab emtansine (also known as T-DM1) is an antibody-drug conjugate (ADC) approved for the treatment of HER2-positive breast cancer. While the treatment with T-DM1 resu...
Tallennettuna:
| Julkaisussa: | Antib Ther |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7998064/ https://ncbi.nlm.nih.gov/pubmed/33937626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tbab005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|